These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 9369972)

  • 1. Adenosine A1 receptor agonists as clinically viable agents for treatment of ischemic brain disorders.
    Bischofberger N; Jacobson KA; von Lubitz DK
    Ann N Y Acad Sci; 1997 Oct; 825():23-9. PubMed ID: 9369972
    [No Abstract]   [Full Text] [Related]  

  • 2. Essential role of adenosine, adenosine A1 receptors, and ATP-sensitive K+ channels in cerebral ischemic preconditioning.
    Heurteaux C; Lauritzen I; Widmann C; Lazdunski M
    Proc Natl Acad Sci U S A; 1995 May; 92(10):4666-70. PubMed ID: 7753861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenosine and cerebral ischemia: therapeutic future or death of a brave concept?
    Von Lubitz DK
    Eur J Pharmacol; 1999 Jan; 365(1):9-25. PubMed ID: 9988118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenosine A2A receptors and neuroprotection.
    Ongini E; Adami M; Ferri C; Bertorelli R
    Ann N Y Acad Sci; 1997 Oct; 825():30-48. PubMed ID: 9369973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain adenosine receptors as targets for therapeutic intervention in neurodegenerative diseases.
    Abbracchio MP; Cattabeni F
    Ann N Y Acad Sci; 1999; 890():79-92. PubMed ID: 10668415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenosine and cerebral ischemia: therapeutic future or death of a brave concept?
    von Lubitz DK
    Eur J Pharmacol; 1999 Apr; 371(1):85-102. PubMed ID: 10355598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenosine A3 receptor stimulation and cerebral ischemia.
    Von Lubitz DK; Lin RC; Popik P; Carter MF; Jacobson KA
    Eur J Pharmacol; 1994 Sep; 263(1-2):59-67. PubMed ID: 7821362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative characteristics of A1-receptor agonists as neuroprotective agents].
    Kulinskiĭ VI; Minakina LN; Usov LA
    Eksp Klin Farmakol; 2001; 64(5):19-22. PubMed ID: 11764492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic potential for adenosine receptor activation in ischemic brain injury.
    Miller LP; Hsu C
    J Neurotrauma; 1992 May; 9 Suppl 2():S563-77. PubMed ID: 1613814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenosine A1 receptor activation preferentially protects cultured cerebellar neurons versus astrocytes against hypoxia-induced death.
    Logan M; Sweeney MI
    Mol Chem Neuropathol; 1997 Jun; 31(2):119-33. PubMed ID: 9376019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of postischemic brain damage and memory deficits following treatment with the selective adenosine A1 receptor agonist.
    Von Lubitz DK; Beenhakker M; Lin RC; Carter MF; Paul IA; Bischofberger N; Jacobson KA
    Eur J Pharmacol; 1996 Apr; 302(1-3):43-8. PubMed ID: 8790990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The comparative characteristics and receptor mechanism of the effect of adenosine-receptor agonists in total cerebral ischemia].
    Kulinskiĭ VI; Usov LA; Sufianova GZ; Lidak MIu; Iurkevich AM
    Eksp Klin Farmakol; 1993; 56(6):13-6. PubMed ID: 8111286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of apoptosis by adenosine in the central nervous system: a possible role for the A3 receptor. Pathophysiological significance and therapeutic implications for neurodegenerative disorders.
    Abbracchio MP; Ceruti S; Brambilla R; Franceschi C; Malorni W; Jacobson KA; von Lubitz DK; Cattabeni F
    Ann N Y Acad Sci; 1997 Oct; 825():11-22. PubMed ID: 9369971
    [No Abstract]   [Full Text] [Related]  

  • 14. Cerebral ischemia in gerbils: effects of acute and chronic treatment with adenosine A2A receptor agonist and antagonist.
    Von Lubitz DK; Lin RC; Jacobson KA
    Eur J Pharmacol; 1995 Dec; 287(3):295-302. PubMed ID: 8991804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection against ischemic damage by adenosine amine congener, a potent and selective adenosine A1 receptor agonist.
    Von Lubitz DK; Lin RC; Bischofberger N; Beenhakker M; Boyd M; Lipartowska R; Jacobson KA
    Eur J Pharmacol; 1999 Mar; 369(3):313-7. PubMed ID: 10225368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of cyclopentyladenosine on lipid peroxidation during focal cerebral ischemia.
    Sufianova GZ; Sufianov AA; Shapkin AG
    Bull Exp Biol Med; 2014 Jun; 157(2):228-30. PubMed ID: 24952491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of central effects of peripherally administered adenosine A(1) agonists on synaptic transmission in the rat hippocampus.
    Gervitz LM; Lutherer LO; Hamilton ME; Fowler JC
    Brain Res; 2002 Sep; 951(1):141-5. PubMed ID: 12231468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of adenosine receptor agonists on the normal cerebral blood flow and in subsequent ischemia].
    Kulinskiĭ VI; Sufianova GZ; Usov LA; Ekimov EN
    Eksp Klin Farmakol; 1996; 59(3):37-9. PubMed ID: 8974582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective effects of adenosine in cerebral ischemia: window of opportunity.
    Sweeney MI
    Neurosci Biobehav Rev; 1997 Mar; 21(2):207-17. PubMed ID: 9062944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraspinal injection of adenosine agonists protect against L-NAME induced neuronal loss in the rat.
    Dora CD; Koch S; Sanchez A; Ruenes G; Liu S; Yezierski RP
    J Neurotrauma; 1998 Jul; 15(7):473-83. PubMed ID: 9674551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.